A Chikungunya Fever Vaccine Utilizing an Insect-Specific Virus Platform

Traditionally, vaccine development involves tradeoffs between immunogenicity and safety. Live-attenuated vaccines typically offer rapid and durable immunity but reduced safety, while the inability of inactivated vaccines to replicate enhances safety at the expense of immunogenicity, often necessitat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nat Med
Autors principals: Erasmus, Jesse H., Auguste, Albert J., Kaelber, Jason T., Luo, Huanle, Rossi, Shannan L., Fenton, Karla, Leal, Grace, Kim, Dal Y., Chiu, Wah, Wang, Tian, Frolov, Ilya, Nasar, Farooq, Weaver, Scott C.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5296253/
https://ncbi.nlm.nih.gov/pubmed/27991917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.4253
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars